Background: Visible analytics (VA) promotes the understanding of information with visible, interactive strategies, utilizing analytic and visible engines. The analytic engine contains automated strategies, whereas frequent visible outputs embrace circulation maps and spatiotemporal sizzling spots.
Goal: This scoping assessment goals to handle a spot within the literature, with the precise goal to synthesize literature on the usage of VA instruments, strategies, and frameworks in interrelated well being care areas of inhabitants well being and well being companies analysis (HSR).
Strategies: Utilizing the 2018 PRISMA-ScR (Most well-liked Reporting Objects for Systematic Critiques and Meta-Analyses Extension for Scoping Critiques) tips, the assessment focuses on peer-reviewed journal articles and full convention papers from 2005 to March 2019. Two analysisers have been concerned at every step, and one other analysiser arbitrated disagreements. A complete abstraction platform captured knowledge from various our bodies of the literature, primarily from the pc and well being sciences.
Outcomes: After screening 11,310 articles, findings from 55 articles have been synthesized underneath the most important headings of visible and analytic engines, visible presentation traits, instruments used and their capabilities, utility to well being care areas, knowledge sorts and sources, VA frameworks, frameworks used for VA functions, availability and innovation, and co-design initiatives. We discovered in depth utility of VA strategies utilized in areas of epidemiology, surveillance and modeling, well being companies entry, use, and value analyses. All articles included a definite analytic and visualization engine, with various ranges of element offered. Most instruments have been prototypes, with 5 in use on the time of publication. Seven articles introduced methodological frameworks. Towards constant reporting, we current a guidelines, with an expanded definition for VA functions in well being care, to help analysisers in sharing analysis for higher replicability. We summarized the leads to a Tableau dashboard.
Conclusions: With the rising availability and technology of massive well being care knowledge, VA is a fast-growing methodology utilized to complicated well being care knowledge. What makes VA revolutionary is its functionality to course of a number of, different knowledge sources to show tendencies and patterns for exploratory evaluation, resulting in information technology and determination help. That is the primary assessment to bridge a important hole within the literature on VA strategies utilized to the areas of inhabitants well being and HSR, which additional signifies potential avenues for the adoption of those strategies sooner or later. This assessment is very necessary within the wake of COVID-19 surveillance and response initiatives, the place many VA merchandise have taken heart stage.
Microbial biosurfactant analysis: time to enhance the rigour within the reporting of synthesis, practical characterization and course of growth
The demand for microbially produced surface-active compounds to be used in industrial processes and merchandise is rising. As such, there was a comparable enhance within the variety of publications regarding the characterization of novel surface-active compounds: novel producers of already characterised surface-active compounds and manufacturing processes for the technology of those compounds. Main analysisers within the subject have recognized that many of those research make the most of strategies are usually not exact and correct sufficient, so some printed conclusions won’t be justified.
Such research missing sturdy experimental proof generated by validated strategies and commonplace working procedures are detrimental to the sector of microbially produced surface-active compound analysis. On this publication, we’ve got critically reviewed a variety of strategies utilized within the characterization of surface-active compounds from microbial sources: identification of surface-active compound producing microorganisms and practical testing of resultant surface-active compounds. We’ve additionally reviewed the experimental proof required for course of growth to take these compounds out of the laboratory and into industrial utility.
We devised this assessment as a information to each analysisers and the peer-reviewed course of to enhance the stringency of future research and publications inside this subject of science.
Visual Analytic Tools and Techniques in Population Health and Health Services Research: Scoping Review
Molecular mechanisms underlying the anticancer actions of licorice flavonoids
Ethnopharmacological relevance: Licorice has been generally utilized in conventional Chinese language medication for remedy of gastric, liver, and respiratory illness circumstances for greater than two thousand years. It’s a main element of a number of Chinese language patent medicines certificated by Nationwide Medical Merchandise Administration that possess nice anticancer actions.
Goal of the examine: To comprehensively summarize the anticancer actions of licorice flavonoids, clarify the underlying molecular mechanisms, assess their therapeutic potentials and side-effects.
Strategies: PubMed, Analysis Gate, Internet of Science, Google Scholar, educational journals, and Science Direct have been used as data sources, with the important thing phrases of “anticancer”, “licorice”, “flavonoids”, and their combos, primarily from 2000 to 2019.
Outcomes: Sixteen licorice flavonoids are discovered to own anticancer actions. These flavonoids inhibit most cancers cells by way of blocking cell cycle and regulating a number of signaling pathways. The foremost pathways focused by licorice flavonoids embrace: the MAPK pathway, PI3K/AKT pathway, NF-κB pathway, dying receptor – dependent extrinsic signaling pathway, and mitochondrial apoptotic pathway.
 Antibody) B-Cell Activation Factor Receptor (BAFFR) Antibody |
|
20-abx103563 |
Abbexa |
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
|
- 10 ug
- 50 ug
- 100 ug
- 200 ug
- 1 mg
|
|
|
B-Cell Activation Factor Receptor (BAFFR) Antibody |
|
20-abx103564 |
Abbexa |
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
|
- 10 ug
- 50 ug
- 100 ug
- 200 ug
- 1 mg
|
|
|
 Antibody) B-Cell Activation Factor Receptor (TNFRSF13C) Antibody |
|
abx412204-50ug |
Abbexa |
50 ug |
EUR 610.8 |
|
|
B-Cell Activation Factor Receptor (TNFRSF13C) Antibody |
|
abx412609-01mg |
Abbexa |
0.1 mg |
EUR 510 |
|
|
B-Cell Activation Factor Receptor (TNFRSF13C) Antibody |
|
abx415317-01mg |
Abbexa |
0.1 mg |
EUR 543.6 |
|
|
 Antibody (PE)) B-Cell Activation Factor Receptor (BAFFR) Antibody (PE) |
|
20-abx270986 |
Abbexa |
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
|
- 25 tests
- 50 tests
- 100 tests
- 200 tests
- 500 tests
|
|
|
 Antibody (APC)) B-Cell Activation Factor Receptor (BAFFR) Antibody (APC) |
|
20-abx270754 |
Abbexa |
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
|
- 25 tests
- 50 tests
- 100 tests
- 200 tests
- 500 tests
|
|
|
 Antibody (FITC)) B-Cell Activation Factor Receptor (BAFFR) Antibody (FITC) |
|
20-abx271119 |
Abbexa |
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
|
- 10 ug
- 50 ug
- 100 ug
- 200 ug
- 1 mg
|
|
|
B-Cell Activation Factor Receptor (BAFFR) Antibody (FITC) |
|
20-abx270522 |
Abbexa |
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
|
- 25 tests
- 50 tests
- 100 tests
- 200 tests
- 500 tests
|
|
|
 Antibody (Biotin)) B-Cell Activation Factor Receptor (BAFFR) Antibody (Biotin) |
|
20-abx273354 |
Abbexa |
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
|
- 10 ug
- 50 ug
- 100 ug
- 200 ug
- 1 mg
|
|
|
B-Cell Activation Factor Receptor (BAFFR) Antibody (Biotin) |
|
20-abx271385 |
Abbexa |
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
|
- 10 ug
- 50 ug
- 100 ug
- 200 ug
- 1 mg
|
|
|
 Antibody) B-Cell Activation Factor Receptor / BAFFR (TNFRSF13C) Antibody |
|
abx213043-100l |
Abbexa |
100 µl |
EUR 350 |
B-Cell Activation Factor Receptor / BAFFR (TNFRSF13C) Antibody |
|
abx213043-50l |
Abbexa |
50 µl |
EUR 250 |
B-Cell Activation Factor Receptor / BAFFR (TNFRSF13C) Antibody |
|
abx140556-100g |
Abbexa |
100 µg |
EUR 337.5 |
B-Cell Activation Factor Receptor / BAFFR (TNFRSF13C) Antibody |
|
abx130816-100l |
Abbexa |
100 µl |
EUR 262.5 |
B-Cell Activation Factor Receptor / BAFFR (TNFRSF13C) Antibody |
|
abx130816-500l |
Abbexa |
500 µl |
EUR 337.5 |
B-Cell Activation Factor Receptor / BAFFR (TNFRSF13C) Antibody |
|
abx412609-100g |
Abbexa |
100 µg |
EUR 462.5 |
B-Cell Activation Factor Receptor / BAFFR (TNFRSF13C) Antibody |
|
abx415317-200l |
Abbexa |
200 µl |
EUR 362.5 |
B-Cell Activation Factor Receptor / BAFFR (TNFRSF13C) Antibody |
|
abx171390-1ml |
Abbexa |
1 ml |
EUR 712.5 |
B-Cell Activation Factor Receptor / BAFFR (TNFRSF13C) Antibody |
|
abx211966-100l |
Abbexa |
100 µl |
EUR 350 |
B-Cell Activation Factor Receptor / BAFFR (TNFRSF13C) Antibody |
|
abx211966-50l |
Abbexa |
50 µl |
EUR 250 |
B-Cell Activation Factor Receptor / BAFFR (TNFRSF13C) Antibody |
|
abx128507-100l |
Abbexa |
100 µl |
EUR 250 |
B-Cell Activation Factor Receptor / BAFFR (TNFRSF13C) Antibody |
|
abx128507-1ml |
Abbexa |
1 ml |
EUR 675 |
B-Cell Activation Factor Receptor / BAFFR (TNFRSF13C) Antibody |
|
abx128507-200l |
Abbexa |
200 µl |
EUR 312.5 |
B-Cell Activation Factor Receptor / BAFFR (TNFRSF13C) Antibody |
|
abx270224-1ml |
Abbexa |
1 ml |
EUR 425 |
B-Cell Activation Factor Receptor / BAFFR (TNFRSF13C) Antibody |
|
abx270224-200l |
Abbexa |
200 µl |
EUR 300 |
B-Cell Activation Factor Receptor / BAFFR (TNFRSF13C) Antibody |
|
abx310259-100g |
Abbexa |
100 µg |
EUR 362.5 |
B-Cell Activation Factor Receptor / BAFFR (TNFRSF13C) Antibody |
|
abx310259-20g |
Abbexa |
20 µg |
EUR 162.5 |
B-Cell Activation Factor Receptor / BAFFR (TNFRSF13C) Antibody |
|
abx310259-50g |
Abbexa |
50 µg |
EUR 250 |
B-Cell Activation Factor Receptor / BAFFR (TNFRSF13C) Antibody |
|
abx103561-100g |
Abbexa |
100 µg |
EUR 675 |
B-Cell Activation Factor Receptor / BAFFR (TNFRSF13C) Antibody |
|
abx103561-20g |
Abbexa |
20 µg |
EUR 250 |
B-Cell Activation Factor Receptor / BAFFR (TNFRSF13C) Antibody |
|
abx103561-50g |
Abbexa |
50 µg |
EUR 312.5 |
B-Cell Activation Factor Receptor / BAFFR (TNFRSF13C) Antibody |
|
abx103562-100g |
Abbexa |
100 µg |
EUR 687.5 |
B-Cell Activation Factor Receptor / BAFFR (TNFRSF13C) Antibody |
|
abx103562-20g |
Abbexa |
20 µg |
EUR 262.5 |
B-Cell Activation Factor Receptor / BAFFR (TNFRSF13C) Antibody |
|
abx103562-50g |
Abbexa |
50 µg |
EUR 325 |
B-Cell Activation Factor Receptor / BAFFR (TNFRSF13C) Antibody |
|
abx103563-100g |
Abbexa |
100 µg |
EUR 725 |
B-Cell Activation Factor Receptor / BAFFR (TNFRSF13C) Antibody |
|
abx103563-20g |
Abbexa |
20 µg |
EUR 262.5 |
B-Cell Activation Factor Receptor / BAFFR (TNFRSF13C) Antibody |
|
abx103563-50g |
Abbexa |
50 µg |
EUR 337.5 |
B-Cell Activation Factor Receptor / BAFFR (TNFRSF13C) Antibody |
|
abx103564-100g |
Abbexa |
100 µg |
EUR 725 |
B-Cell Activation Factor Receptor / BAFFR (TNFRSF13C) Antibody |
|
abx103564-20g |
Abbexa |
20 µg |
EUR 262.5 |
B-Cell Activation Factor Receptor / BAFFR (TNFRSF13C) Antibody |
|
abx103564-50g |
Abbexa |
50 µg |
EUR 337.5 |
 Monoclonal Antibody) B-Cell Activation Factor Receptor (BAFFR) Monoclonal Antibody |
|
CAU30615-100ul |
Biomatik Corporation |
100ul |
EUR 225.6 |
B-Cell Activation Factor Receptor (BAFFR) Monoclonal Antibody |
|
CAU30615-200ul |
Biomatik Corporation |
200ul |
EUR 282.2 |
 Polyclonal Antibody) B-Cell Activation Factor Receptor (BAFFR) Polyclonal Antibody |
|
CAU28193-100ul |
Biomatik Corporation |
100ul |
EUR 229.4 |
B-Cell Activation Factor Receptor (BAFFR) Polyclonal Antibody |
|
CAU28193-200ul |
Biomatik Corporation |
200ul |
EUR 287.3 |
B-Cell Activation Factor Receptor (BAFFR) Polyclonal Antibody |
|
CAU28194-100ul |
Biomatik Corporation |
100ul |
EUR 229.4 |
B-Cell Activation Factor Receptor (BAFFR) Polyclonal Antibody |
|
CAU28194-200ul |
Biomatik Corporation |
200ul |
EUR 287.3 |
B-Cell Activation Factor Receptor (BAFFR) Polyclonal Antibody |
|
CAU28195-100ul |
Biomatik Corporation |
100ul |
EUR 217.9 |
B-Cell Activation Factor Receptor (BAFFR) Polyclonal Antibody |
|
CAU28195-200ul |
Biomatik Corporation |
200ul |
EUR 272.2 |
B-Cell Activation Factor Receptor (BAFFR) Polyclonal Antibody |
|
CAU28196-100ul |
Biomatik Corporation |
100ul |
EUR 211.2 |
B-Cell Activation Factor Receptor (BAFFR) Polyclonal Antibody |
|
CAU28196-200ul |
Biomatik Corporation |
200ul |
EUR 263.8 |
B-Cell Activation Factor Receptor (BAFFR) Polyclonal Antibody |
|
CAU28197-100ul |
Biomatik Corporation |
100ul |
EUR 212.2 |
B-Cell Activation Factor Receptor (BAFFR) Polyclonal Antibody |
|
CAU28197-200ul |
Biomatik Corporation |
200ul |
EUR 265.4 |
B-Cell Activation Factor Receptor (BAFFR) Polyclonal Antibody |
|
CAU28198-100ul |
Biomatik Corporation |
100ul |
EUR 229.4 |
B-Cell Activation Factor Receptor (BAFFR) Polyclonal Antibody |
|
CAU28198-200ul |
Biomatik Corporation |
200ul |
EUR 287.3 |
B-Cell Activation Factor Receptor (BAFFR) Polyclonal Antibody |
|
MBS2032174-01mL |
MyBiosource |
0.1mL |
EUR 170 |
B-Cell Activation Factor Receptor (BAFFR) Polyclonal Antibody |
|
MBS2032174-02mL |
MyBiosource |
0.2mL |
EUR 215 |
B-Cell Activation Factor Receptor (BAFFR) Polyclonal Antibody |
|
MBS2032174-05mL |
MyBiosource |
0.5mL |
EUR 350 |
B-Cell Activation Factor Receptor (BAFFR) Polyclonal Antibody |
|
MBS2032174-1mL |
MyBiosource |
1mL |
EUR 425 |
B-Cell Activation Factor Receptor (BAFFR) Polyclonal Antibody |
|
MBS2032174-5mL |
MyBiosource |
5mL |
EUR 1160 |
 Antibody (PE)) B-Cell Activation Factor Receptor / BAFFR (TNFRSF13C) Antibody (PE) |
|
abx270986-1ml |
Abbexa |
1 ml |
EUR 1125 |
B-Cell Activation Factor Receptor / BAFFR (TNFRSF13C) Antibody (PE) |
|
abx270986-200l |
Abbexa |
200 µl |
EUR 687.5 |
 Antibody (APC)) B-Cell Activation Factor Receptor / BAFFR (TNFRSF13C) Antibody (APC) |
|
abx270754-1ml |
Abbexa |
1 ml |
EUR 1312.5 |
B-Cell Activation Factor Receptor / BAFFR (TNFRSF13C) Antibody (APC) |
|
abx270754-200l |
Abbexa |
200 µl |
EUR 800 |
 Antibody (HRP)) B-Cell Activation Factor Receptor / BAFFR (TNFRSF13C) Antibody (HRP) |
|
abx310260-100g |
Abbexa |
100 µg |
EUR 362.5 |
B-Cell Activation Factor Receptor / BAFFR (TNFRSF13C) Antibody (HRP) |
|
abx310260-20g |
Abbexa |
20 µg |
EUR 162.5 |
B-Cell Activation Factor Receptor / BAFFR (TNFRSF13C) Antibody (HRP) |
|
abx310260-50g |
Abbexa |
50 µg |
EUR 250 |
) Monoclonal Antibody to B-Cell Activation Factor Receptor (BAFFR) |
|
MBS2111536-INQUIRE |
MyBiosource |
INQUIRE |
Ask for price |
) Polyclonal Antibody to B-Cell Activation Factor Receptor (BAFFR) |
|
MBS2001869-01mL |
MyBiosource |
0.1mL |
EUR 170 |
Polyclonal Antibody to B-Cell Activation Factor Receptor (BAFFR) |
|
MBS2001869-02mL |
MyBiosource |
0.2mL |
EUR 215 |
Polyclonal Antibody to B-Cell Activation Factor Receptor (BAFFR) |
|
MBS2001869-05mL |
MyBiosource |
0.5mL |
EUR 350 |
Polyclonal Antibody to B-Cell Activation Factor Receptor (BAFFR) |
|
MBS2001869-1mL |
MyBiosource |
1mL |
EUR 425 |
Polyclonal Antibody to B-Cell Activation Factor Receptor (BAFFR) |
|
MBS2001869-5mL |
MyBiosource |
5mL |
EUR 1160 |
Polyclonal Antibody to B-Cell Activation Factor Receptor (BAFFR) |
|
MBS2004314-01mL |
MyBiosource |
0.1mL |
EUR 165 |
Polyclonal Antibody to B-Cell Activation Factor Receptor (BAFFR) |
|
MBS2004314-02mL |
MyBiosource |
0.2mL |
EUR 200 |
Polyclonal Antibody to B-Cell Activation Factor Receptor (BAFFR) |
|
MBS2004314-05mL |
MyBiosource |
0.5mL |
EUR 325 |
Polyclonal Antibody to B-Cell Activation Factor Receptor (BAFFR) |
|
MBS2004314-1mL |
MyBiosource |
1mL |
EUR 395 |
Polyclonal Antibody to B-Cell Activation Factor Receptor (BAFFR) |
|
MBS2004314-5mL |
MyBiosource |
5mL |
EUR 1075 |
Polyclonal Antibody to B-Cell Activation Factor Receptor (BAFFR) |
|
MBS2005294-01mL |
MyBiosource |
0.1mL |
EUR 170 |
Polyclonal Antibody to B-Cell Activation Factor Receptor (BAFFR) |
|
MBS2005294-02mL |
MyBiosource |
0.2mL |
EUR 215 |
Polyclonal Antibody to B-Cell Activation Factor Receptor (BAFFR) |
|
MBS2005294-05mL |
MyBiosource |
0.5mL |
EUR 350 |
Polyclonal Antibody to B-Cell Activation Factor Receptor (BAFFR) |
|
MBS2005294-1mL |
MyBiosource |
1mL |
EUR 425 |
Polyclonal Antibody to B-Cell Activation Factor Receptor (BAFFR) |
|
MBS2005294-5mL |
MyBiosource |
5mL |
EUR 1160 |
Polyclonal Antibody to B-Cell Activation Factor Receptor (BAFFR) |
|
MBS2027259-01mL |
MyBiosource |
0.1mL |
EUR 170 |
Polyclonal Antibody to B-Cell Activation Factor Receptor (BAFFR) |
|
MBS2027259-02mL |
MyBiosource |
0.2mL |
EUR 205 |
Polyclonal Antibody to B-Cell Activation Factor Receptor (BAFFR) |
|
MBS2027259-05mL |
MyBiosource |
0.5mL |
EUR 330 |
Polyclonal Antibody to B-Cell Activation Factor Receptor (BAFFR) |
|
MBS2027259-1mL |
MyBiosource |
1mL |
EUR 405 |
Polyclonal Antibody to B-Cell Activation Factor Receptor (BAFFR) |
|
MBS2027259-5mL |
MyBiosource |
5mL |
EUR 1100 |
Polyclonal Antibody to B-Cell Activation Factor Receptor (BAFFR) |
|
MBS2027128-01mL |
MyBiosource |
0.1mL |
EUR 165 |
Polyclonal Antibody to B-Cell Activation Factor Receptor (BAFFR) |
|
MBS2027128-02mL |
MyBiosource |
0.2mL |
EUR 200 |
Polyclonal Antibody to B-Cell Activation Factor Receptor (BAFFR) |
|
MBS2027128-05mL |
MyBiosource |
0.5mL |
EUR 320 |
Polyclonal Antibody to B-Cell Activation Factor Receptor (BAFFR) |
|
MBS2027128-1mL |
MyBiosource |
1mL |
EUR 395 |
Polyclonal Antibody to B-Cell Activation Factor Receptor (BAFFR) |
|
MBS2027128-5mL |
MyBiosource |
5mL |
EUR 1070 |
Polyclonal Antibody to B-Cell Activation Factor Receptor (BAFFR) |
|
PAA281Ga01 |
Cloud-Clone |
100ul |
EUR 239 |
|
|
Polyclonal Antibody to B-Cell Activation Factor Receptor (BAFFR) |
|
PAA281Hu01 |
Cloud-Clone |
100ul |
EUR 221 |
|
|
Polyclonal Antibody to B-Cell Activation Factor Receptor (BAFFR) |
|
PAA281Hu02 |
Cloud-Clone |
100ul |
EUR 220 |
|
|
Polyclonal Antibody to B-Cell Activation Factor Receptor (BAFFR) |
|
PAA281Mu01 |
Cloud-Clone |
100ul |
EUR 227 |
|
|
Polyclonal Antibody to B-Cell Activation Factor Receptor (BAFFR) |
|
PAA281Ra01 |
Cloud-Clone |
100ul |
EUR 239 |
|
|
Polyclonal Antibody to B-Cell Activation Factor Receptor (BAFFR) |
|
PAA281Ra02 |
Cloud-Clone |
100ul |
EUR 239 |
|
|
) Recombinant Antibody to B-Cell Activation Factor Receptor (BAFFR) |
|
RAA281Hu21 |
Cloud-Clone |
100ul |
EUR 399 |
|
|
 Antibody (FITC)) B-Cell Activation Factor Receptor / BAFFR (TNFRSF13C) Antibody (FITC) |
|
abx271119-1ml |
Abbexa |
1 ml |
EUR 950 |
B-Cell Activation Factor Receptor / BAFFR (TNFRSF13C) Antibody (FITC) |
|
abx271119-200l |
Abbexa |
200 µl |
EUR 400 |
B-Cell Activation Factor Receptor / BAFFR (TNFRSF13C) Antibody (FITC) |
|
abx270522-1ml |
Abbexa |
1 ml |
EUR 912.5 |
B-Cell Activation Factor Receptor / BAFFR (TNFRSF13C) Antibody (FITC) |
|
abx270522-200l |
Abbexa |
200 µl |
EUR 575 |
B-Cell Activation Factor Receptor / BAFFR (TNFRSF13C) Antibody (FITC) |
|
abx310261-100g |
Abbexa |
100 µg |
EUR 362.5 |
B-Cell Activation Factor Receptor / BAFFR (TNFRSF13C) Antibody (FITC) |
|
abx310261-20g |
Abbexa |
20 µg |
EUR 162.5 |
B-Cell Activation Factor Receptor / BAFFR (TNFRSF13C) Antibody (FITC) |
|
abx310261-50g |
Abbexa |
50 µg |
EUR 250 |
 Polyclonal Antibody (Rat)) B-Cell Activation Factor Receptor (BAFFR) Polyclonal Antibody (Rat) |
|
4-PAA281Ra01 |
Cloud-Clone |
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
|
- 20ul
- 100ul
- 200ul
- 1ml
- 10ml
|
|
|
|
Description: A Rabbit polyclonal antibody against Rat B-Cell Activation Factor Receptor (BAFFR) |
B-Cell Activation Factor Receptor (BAFFR) Polyclonal Antibody (Rat) |
|
4-PAA281Ra02 |
Cloud-Clone |
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
|
- 20ul
- 100ul
- 200ul
- 1ml
- 10ml
|
|
|
|
Description: A Rabbit polyclonal antibody against Rat B-Cell Activation Factor Receptor (BAFFR) |
 Antibody (Biotin)) B-Cell Activation Factor Receptor / BAFFR (TNFRSF13C) Antibody (Biotin) |
|
abx273354-25mg |
Abbexa |
25 mg |
EUR 900 |
B-Cell Activation Factor Receptor / BAFFR (TNFRSF13C) Antibody (Biotin) |
|
abx273354-5mg |
Abbexa |
5 mg |
EUR 387.5 |
B-Cell Activation Factor Receptor / BAFFR (TNFRSF13C) Antibody (Biotin) |
|
abx271385-1ml |
Abbexa |
1 ml |
EUR 737.5 |
B-Cell Activation Factor Receptor / BAFFR (TNFRSF13C) Antibody (Biotin) |
|
abx271385-200l |
Abbexa |
200 µl |
EUR 337.5 |
B-Cell Activation Factor Receptor / BAFFR (TNFRSF13C) Antibody (Biotin) |
|
abx310262-100g |
Abbexa |
100 µg |
EUR 362.5 |
B-Cell Activation Factor Receptor / BAFFR (TNFRSF13C) Antibody (Biotin) |
|
abx310262-20g |
Abbexa |
20 µg |
EUR 162.5 |
B-Cell Activation Factor Receptor / BAFFR (TNFRSF13C) Antibody (Biotin) |
|
abx310262-50g |
Abbexa |
50 µg |
EUR 250 |
 Polyclonal Antibody (Human)) B-Cell Activation Factor Receptor (BAFFR) Polyclonal Antibody (Human) |
|
4-PAA281Hu01 |
Cloud-Clone |
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
|
- 20ul
- 100ul
- 200ul
- 1ml
- 10ml
|
|
|
|
Description: A Rabbit polyclonal antibody against Human B-Cell Activation Factor Receptor (BAFFR) |
B-Cell Activation Factor Receptor (BAFFR) Polyclonal Antibody (Human) |
|
4-PAA281Hu02 |
Cloud-Clone |
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
|
- 20ul
- 100ul
- 200ul
- 1ml
- 10ml
|
|
|
|
Description: A Rabbit polyclonal antibody against Human B-Cell Activation Factor Receptor (BAFFR) |
 Polyclonal Antibody (Chicken)) B-Cell Activation Factor Receptor (BAFFR) Polyclonal Antibody (Chicken) |
|
4-PAA281Ga01 |
Cloud-Clone |
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
|
- 20ul
- 100ul
- 200ul
- 1ml
- 10ml
|
|
|
|
Description: A Rabbit polyclonal antibody against Chicken B-Cell Activation Factor Receptor (BAFFR) |
) FITC-linked Antibody to B-Cell Activation Factor Receptor (BAFFR) |
|
MBS2015174-01mL |
MyBiosource |
0.1mL |
EUR 200 |
FITC-linked Antibody to B-Cell Activation Factor Receptor (BAFFR) |
|
MBS2015174-02mL |
MyBiosource |
0.2mL |
EUR 250 |
FITC-linked Antibody to B-Cell Activation Factor Receptor (BAFFR) |
|
MBS2015174-05mL |
MyBiosource |
0.5mL |
EUR 440 |
FITC-linked Antibody to B-Cell Activation Factor Receptor (BAFFR) |
|
MBS2015174-1mL |
MyBiosource |
1mL |
EUR 535 |
FITC-linked Antibody to B-Cell Activation Factor Receptor (BAFFR) |
|
MBS2015174-5mL |
MyBiosource |
5mL |
EUR 1490 |
 Polyclonal Antibody (Rat), PE) B-Cell Activation Factor Receptor (BAFFR) Polyclonal Antibody (Rat), PE |
|
4-PAA281Ra01-PE |
Cloud-Clone |
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
|
- 20ul
- 100ul
- 200ul
- 1ml
- 10ml
|
|
|
|
Description: A Rabbit polyclonal antibody against Rat B-Cell Activation Factor Receptor (BAFFR). This antibody is labeled with PE. |
B-Cell Activation Factor Receptor (BAFFR) Polyclonal Antibody (Rat), PE |
|
4-PAA281Ra02-PE |
Cloud-Clone |
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
|
- 20ul
- 100ul
- 200ul
- 1ml
- 10ml
|
|
|
|
Description: A Rabbit polyclonal antibody against Rat B-Cell Activation Factor Receptor (BAFFR). This antibody is labeled with PE. |
) Biotin-Linked Antibody to B-Cell Activation Factor Receptor (BAFFR) |
|
MBS2002896-01mL |
MyBiosource |
0.1mL |
EUR 180 |
Biotin-Linked Antibody to B-Cell Activation Factor Receptor (BAFFR) |
|
MBS2002896-02mL |
MyBiosource |
0.2mL |
EUR 225 |
Biotin-Linked Antibody to B-Cell Activation Factor Receptor (BAFFR) |
|
MBS2002896-05mL |
MyBiosource |
0.5mL |
EUR 380 |
Biotin-Linked Antibody to B-Cell Activation Factor Receptor (BAFFR) |
|
MBS2002896-1mL |
MyBiosource |
1mL |
EUR 465 |
Biotin-Linked Antibody to B-Cell Activation Factor Receptor (BAFFR) |
|
MBS2002896-5mL |
MyBiosource |
5mL |
EUR 1270 |
Biotin-Linked Antibody to B-Cell Activation Factor Receptor (BAFFR) |
|
MBS2004364-01mL |
MyBiosource |
0.1mL |
EUR 175 |
Conclusion: Licorice flavonoids are a bunch of versatile molecules which have pleiotropic results on cell development, survival and cell signaling. Lots of the flavonoids possess inhibitory actions towards most cancers cell development and therefore have an incredible therapeutic potential in most cancers remedy. Nonetheless, extra preclinical research are nonetheless wanted to evaluate their in vivo efficacy and potential toxicities. Additionally it is crucial to guage the consequences of licorice flavonoids on the metabolism of different medicine and discover the potential synergistic mechanism.
